Provided by Tiger Trade Technology Pte. Ltd.

Myers

27.97
+0.56002.04%
Post-market: 27.50-0.4700-1.68%18:05 EDT
Volume:371.95K
Turnover:10.36M
Market Cap:1.05B
PE:39.62
High:28.13
Open:27.48
Low:27.29
Close:27.41
52wk High:28.13
52wk Low:12.96
Shares:37.41M
Float Shares:36.71M
Volume Ratio:0.92
T/O Rate:1.01%
Dividend:0.54
Dividend Rate:1.93%
EPS(TTM):0.7060
EPS(LYR):0.9300
ROE:14.67%
ROA:6.73%
PB:3.62
PE(LYR):30.08

Loading ...

Bristol Myers price target raised to $66 from $64 at Citi

TIPRANKS
·
May 01

Bristol Myers reports Q1 adjusted EPS $1.58, consensus $1.42

TIPRANKS
·
Apr 30

Bristol Myers backs FY26 adjusted EPS view $6.05-$6.35, consensus $6.26

TIPRANKS
·
Apr 30

Analysts Offer Insights on Consumer Cyclical Companies: Myers Industries (MYE) and Starbucks (SBUX)

TIPRANKS
·
Apr 29

Myers Industries Shareholders Back Directors, Compensation and Auditor

TIPRANKS
·
Apr 25

Myers Industries shareholders elected directors at annual meeting

Reuters
·
Apr 25

Myers Industries shareholders elect Tribby Warfield to board of directors

Reuters
·
Apr 24

Myers Industries Shareholders Elect Tribby Warfield to Board of Directors

THOMSON REUTERS
·
Apr 24

Bristol Myers price target raised to $54 from $45 at Cantor Fitzgerald

TIPRANKS
·
Apr 08

Janux announces development candidate nomination under Bristol Myers collab

TIPRANKS
·
Apr 01

Myers Industries schedules quarterly earnings report, conference call

Reuters
·
Apr 01

Bristol Myers announces Phase 3 Scout-HCM trial of Camzyos met primary endpoint

TIPRANKS
·
Mar 29

Bristol Myers announces data from Phase 4 trial of Cobenfy

TIPRANKS
·
Mar 29

Myers Industries publishes 2025 annual report

Reuters
·
Mar 24

insitro announces expansion of collaboration with Bristol Myers

TIPRANKS
·
Mar 23

Bristol Myers announces expanded approvals for Opdivo in U.S., EU,

TIPRANKS
·
Mar 21

Bristol Myers Secures FDA Nod For Opdivo Plus Chemo For Untreated Hodgkin Lymphoma

Benzinga
·
Mar 21

Myers Industries Inc. Announces Annual Shareholder Meeting

Reuters
·
Mar 14

Bristol Myers announces U.S. FDA approved Sotyktu for treatment of PsA

TIPRANKS
·
Mar 09

Myers Industries Earnings Call Highlights Margin Momentum

TIPRANKS
·
Mar 07